CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

PR Newswire Biotech
Original article

/C O R R E C T I O N -- Bridge to Life, Ltd./

RegulatoryapprovedVitaSmart™ Hypothermic Oxygenated Perfusion SystemPositive
AI Analysis

Summary

UK NICE issued guidance recommending routine NHS funding for Bridge to Life's VitaSmart Hypothermic Oxygenated Perfusion System. The news release was issued on August 27, 2026 with a correction notice.

Outcome Details

UK NICE issued guidance recommending routine NHS funding

Importance:6/10
Sentiment:
0.70
regulatory approvalNICE guidanceNHS fundingmedical deviceUK

Read the original article

Published by PR Newswire Biotech on August 27, 2026 11:00 PM

Read Original